NASDAQ Stocks Showing Significant Moves (ANDS, IDIX, SNTS)

Anadys Pharmaceuticals, Inc. (NASDAQ:ANDS) surges 19.16% to $3.11 on 5.79 million shares. The company announced that 72% of hepatitis C patients receiving ANA598 400 mg twice daily (bid) plus standard of care (SOC) achieved undetectable levels of virus at week eight in an ongoing Phase II study, compared to 38% of patients receiving placebo plus SOC.

Subscribe to daily free stock newsletter by visiting:  http://www.PennyStockPickReport.com

Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) gains 9.56% to $4.47 on 1.02 million shares. The company announced interim data from a 14-day, phase IIa clinical trial evaluating IDX184, a liver-targeted nucleotide prodrug of 2'-methyl guanosine monophosphate, in HCV-infected patients. In the data presented IDX184 demonstrated potent dose-dependent antiviral activity when combined with PegIFN/RBV.

Santarus, Inc. (NASDAQ:SNTS) falls 35.45% to $3.46 on 4.64 million shares. The company announced that U.S. District Court for the District of Delaware has ruled that five patents covering the Company's ZEGERID (omeprazole/sodium bicarbonate) prescription products are invalid due to obviousness. These patents were the subject of lawsuits brought by Santarus against Par Pharmaceutical, Inc.

About http://www.pennystockpickreport.com/

Penny Stock Pick Report offers stock newsletter on OTC, PINKSHEETS ,OTCBB, AMEX, NASDAQ and NYSE stock exchange. Our subscribers receive daily up to date stock information on hot stocks, most active movers, top gainers, penny stocks and much more. If you wish to feature your organization on our website then you can contact us at the email given below.